| 1 |
Marcovitch L, Focht G, Carmon N, Tersigni C, Ledder O, Lev-Tzion R, Church PC, Hyams JS, Baldassano RN, Bousvaros A, Mack DR, Hussey S, Otley A, Croft NM, Kappelman MD, Griffiths AM, Turner D. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis. Gastroenterology 2023;164:610-618.e4. [PMID: 36539016 DOI: 10.1053/j.gastro.2022.12.006] [Reference Citation Analysis]
|
| 2 |
Vanhelst J, Béghin L, Drumez E, Djeddi-Dine D, Tuck D, Coopman S, Gottrand F, Ley D. Validation of the IMPACT-III Questionnaire in French Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:e71-6. [PMID: 36735394 DOI: 10.1097/MPG.0000000000003716] [Reference Citation Analysis]
|
| 3 |
Boros KK, Veres G, Cseprekál O, Pintér HK, Richter É, Cseh Á, Dezsőfi-Gottl A, Arató A, Reusz G, Dohos D, Müller KE. Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy-an observational follow-up study. Eur J Clin Nutr 2023;77:380-5. [PMID: 36477672 DOI: 10.1038/s41430-022-01245-9] [Reference Citation Analysis]
|
| 4 |
Lund K, Knudsen T, Kjeldsen J, Nielsen RG, Nørgård BM. Health-Related Quality of Life, Anxiety, and Self-Image in Young Patients With Crohn’s Disease and Ulcerative Colitis. JPGN Reports 2023;4:e287. [DOI: 10.1097/pg9.0000000000000287] [Reference Citation Analysis]
|
| 5 |
Kortbeek S, Pawaria A, Ng VL. Equivalence of Paper and Electronic-Based Patient Reported Outcome Measures for Children: A Systematic Review. J Pediatr Gastroenterol Nutr 2023;76:128-36. [PMID: 36240491 DOI: 10.1097/MPG.0000000000003636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Otley A, Day AS, Zachos M. Nutritional Management of Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_27] [Reference Citation Analysis]
|
| 7 |
Hommel KA, Ramsey RR, Gray WN, Denson LA. Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:38-42. [PMID: 36123761 DOI: 10.1097/MPG.0000000000003623] [Reference Citation Analysis]
|
| 8 |
Sahn B, Markowitz J. The Natural History of Crohn Disease in Children. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_7] [Reference Citation Analysis]
|
| 9 |
Grant A, Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_51] [Reference Citation Analysis]
|
| 10 |
Alahmari AA, AlShawaf SH, Meshikhes HA, Aleid BA, Aldossari RM, Shafey MM, Aladsani AA, Al-Ibraheem AA, AlRubia NM, AlQahtani SA. Quality of Life Among Children with Inflammatory Bowel Disease in Saudi Arabia: A Cross-Sectional Study. Int J Gen Med 2022;15:8775-86. [PMID: 36601651 DOI: 10.2147/IJGM.S394914] [Reference Citation Analysis]
|
| 11 |
Berenblum Tobi C. Principles for Assessing Quality of Life in Patients With Crohn's Disease. Am J Gastroenterol 2022;117:1952-3. [PMID: 36455221 DOI: 10.14309/ajg.0000000000002002] [Reference Citation Analysis]
|
| 12 |
Varma A, Weinstein J, Seabury J, Rosero S, Wagner E, Zizzi C, Luebbe E, Dilek N, McDermott M, Heatwole J, Saubermann L, Temple L, Rogoff S, Heatwole C. Patient-Reported Impact of Symptoms in Crohn's Disease. Am J Gastroenterol 2022;117:2033-45. [PMID: 36375002 DOI: 10.14309/ajg.0000000000001954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-Related Quality of Life in Children and Adolescents With Crohn's Disease. Inflamm Bowel Dis 2022;28:1838-43. [PMID: 35166341 DOI: 10.1093/ibd/izac010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 14 |
Lee GW, Chew KS, Wong SY, Chong SY, Ong SY, Lee WS. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population. J Paediatr Child Health 2022;58:1972-9. [PMID: 35880617 DOI: 10.1111/jpc.16130] [Reference Citation Analysis]
|
| 15 |
Roukas C, Syred J, Gordeev VS, Norton C, Hart A, Mihaylova B. Development and test-retest reliability of a new, self-report questionnaire assessing healthcare use and personal costs in people with inflammatory bowel disease: the Inflammatory Bowel Disease Resource Use Questionnaire (IBD-RUQ). Frontline Gastroenterol 2023;14:59-67. [PMID: 36561790 DOI: 10.1136/flgastro-2022-102182] [Reference Citation Analysis]
|
| 16 |
Attauabi M, Madsen GR, Bendtsen F, Wewer AV, Wilkens R, Ilvemark J, Vladimirova N, Jensen AB, Jensen FK, Hansen SB, Siebner HR, Nielsen YJW, Møller JM, Thomsen HS, Thomsen SF, Ingels HAS, Theede K, Boysen T, Bjerrum JT, Jakobsen C, Dorn-Rasmussen M, Jansson S, Yao Y, Burian EA, Møller FT, Fana V, Wiell C, Terslev L, Østergaard M, Bertl K, Stavropoulos A, Seidelin JB, Burisch J. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open 2022;12:e055779. [PMID: 35760545 DOI: 10.1136/bmjopen-2021-055779] [Reference Citation Analysis]
|
| 17 |
Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, Norbruis OF, Wolters VM, van Wering HM, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg-Roord STA, Schreurs MWJ, Rizopoulos D, Doukas M, Escher JC, Samsom JN, de Ridder L. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial. Gut 2022;71:34-42. [PMID: 33384335 DOI: 10.1136/gutjnl-2020-322339] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 18 |
El Amrousy D, El Ashry H, Hodeib H, Hassan S. Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial. J Clin Gastroenterol 2021;55:815-20. [PMID: 33060436 DOI: 10.1097/MCG.0000000000001443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 19 |
Koletzko L, Klucker E, Le Thi TG, Breiteneicher S, Rubio-Acero R, Neuhaus L, Stark RG, Standl M, Wieser A, Török H, Koletzko S, Schwerd T. Following Pediatric and Adult IBD Patients through the COVID-19 Pandemic: Changes in Psychosocial Burden and Perception of Infection Risk and Harm over Time. J Clin Med 2021;10:4124. [PMID: 34575235 DOI: 10.3390/jcm10184124] [Reference Citation Analysis]
|
| 20 |
Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, D'Arcangelo G, Felici E, Fuoti M, Lega S, Panceri R, Pastore M, Penagini F, Gesuita R, Catassi C. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep 2021;11:18076. [PMID: 34508152 DOI: 10.1038/s41598-021-97661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Grant A, Lerer T, Griffiths AM, Hyams J, Otley A. Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone? World J Gastroenterol 2021; 27(30): 5100-5111 [PMID: 34497438 DOI: 10.3748/wjg.v27.i30.5100] [Reference Citation Analysis]
|
| 22 |
Holbein CE, Plevinsky J, Patel T, Conrad MC, Kelsen JR. Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease. J Pediatr Psychol 2021:jsab035. [PMID: 34313785 DOI: 10.1093/jpepsy/jsab035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Calviño-Suárez C, Ferreiro-Iglesias R, Bastón-Rey I, Barreiro-de Acosta M. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment. Int J Environ Res Public Health 2021;18:7159. [PMID: 34281095 DOI: 10.3390/ijerph18137159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Brenner EJ, Long MD, Mann CM, Lin L, Chen W, Reyes C, Bahnson KM, Reeve BB, Kappelman MD. Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2021;73:67-72. [PMID: 33633083 DOI: 10.1097/MPG.0000000000003101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Reed B, Rea KE, Claar RL, van Tilburg MAL, Levy RL. Passive Coping Associations With Self-Esteem and Health-Related Quality of Life in Youth With Inflammatory Bowel Disease. Front Psychol 2021;12:670902. [PMID: 34248766 DOI: 10.3389/fpsyg.2021.670902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
David JG, Chute D, Reed B, Saeed S, DeMatteo D, Atay O, Maddux M, Daly B. Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:143-5. [PMID: 34106253 DOI: 10.1093/ibd/izab154] [Reference Citation Analysis]
|
| 27 |
Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Groeneweg M, de Bruijne FH, Hillegers MHJ, Escher JC, Utens EMWJ. Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up. J Clin Psychol Med Settings 2020;27:490-506. [PMID: 31506853 DOI: 10.1007/s10880-019-09649-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Shih S, Cushman G, Reed B. Temperament and Health-Related Quality of Life in Newly Diagnosed Pediatric Inflammatory Bowel Disease. J Pediatr Psychol 2021;46:404-12. [PMID: 33270892 DOI: 10.1093/jpepsy/jsaa116] [Reference Citation Analysis]
|
| 29 |
Cushman G, Stolz MG, Shih S, Listernick Z, Talmadge C, Gold BD, Reed B. Age, Disease Symptoms, and Depression are Associated With Body Image Dissatisfaction in Newly Diagnosed Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:e57-62. [PMID: 32925551 DOI: 10.1097/MPG.0000000000002943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 30 |
Ahola Kohut S, Stinson J, Jelen A, Ruskin D. Feasibility and Acceptability of a Mindfulness-Based Group Intervention for Adolescents with Inflammatory Bowel Disease. J Clin Psychol Med Settings 2020;27:68-78. [PMID: 31065861 DOI: 10.1007/s10880-019-09622-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 31 |
Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group. Dig Liver Dis 2021;53:183-9. [PMID: 33132063 DOI: 10.1016/j.dld.2020.10.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 32 |
Dotson JL, Boyle B. Crohn Disease. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00042-6] [Reference Citation Analysis]
|
| 33 |
Gourdonneau A, Bruneau L, Ruemmele FM, Norsa L, Takeda A, Le Gall C, Clouzeau H, Rebouissoux L, Dabadie A, Bridoux-Henno L, Rebeuh J, Thomassin N, Viala J, Willot S, Breton A, Coopman S, Spyckerelle C, Languepin J, Bertrand V, Mouterde O, Degas V, Bonneton M, Lemale J, Destombe S, Billiemaz K, Caron N, Borderon C, Dupont C, Triolo V, Jobert A, Lamireau T, Enaud R. Clinical Remission and Psychological Management are Major Issues for the Quality of Life in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:74-9. [PMID: 32740538 DOI: 10.1097/MPG.0000000000002865] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Willis J, Zeratkaar D, Ten Hove J, Rosenbaum P, Ronen GM. Engaging the Voices of Children: A Scoping Review of How Children and Adolescents Are Involved in the Development of Quality-of-Life-Related Measures. Value Health 2021;24:556-67. [PMID: 33840434 DOI: 10.1016/j.jval.2020.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
De Carlo C, Bramuzzo M. Distress, catastrofismo e qualità di vita dei bambini affetti da malattia infiammatoria cronica intestinale. Medico e Bambino 2020;39:634-637. [DOI: 10.53126/meb39634] [Reference Citation Analysis]
|
| 36 |
Hoekman DR, Vlieger AM, Stokkers PC, Mahhmod N, Rietdijk S, de Boer NK, de Meij TG, Frankenhuis C, D'Haens GR, Benninga MA. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial. J Crohns Colitis 2021;15:1106-13. [PMID: 33245332 DOI: 10.1093/ecco-jcc/jjaa241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 37 |
Erős A, Dohos D, Veres G, Tárnok A, Vincze Á, Tészás A, Zádori N, Gede N, Hegyi P, Sarlós P. Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD). BMJ Open 2020;10:e038410. [PMID: 33028560 DOI: 10.1136/bmjopen-2020-038410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Grossman A, Mauer E, Gerber LM, Long MD, Kappelman MD, Gupta N. Black/African American Patients with Pediatric Crohn's Disease Report Less Anxiety and Fatigue than White Patients. J Pediatr 2020;225:146-51. [PMID: 32544479 DOI: 10.1016/j.jpeds.2020.05.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Grant A, MacIntyre B, Kappelman MD, Otley AR. A New Domain Structure for the IMPACT-III Health-related Quality of life Tool for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:494-500. [PMID: 32960540 DOI: 10.1097/MPG.0000000000002824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Navas-López VM, Martel LC, Martín-Masot R, Rubio MN, Santana NR, López MH, Frías Arjona A, Merino Valero VM, Ortega Doltz V, Ramos-Cózar SN, Alcaín Martínez G. The Effect of the Inflammatory Bowel Disease Classroom in Nature on the Quality of Life of Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:243-5. [PMID: 32304559 DOI: 10.1097/MPG.0000000000002746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 41 |
Brenner EJ, Long MD, Mann CM, Chen W, Reyes C, Lin L, Reeve BB, Kappelman MD. Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease. Inflamm Bowel Dis 2021;27:344-51. [PMID: 32435792 DOI: 10.1093/ibd/izaa083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Vanhelst J, Coopman S, Labreuche J, Dupont C, Bertrand V, Djeddi D, Turck D, Ley D. Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel disease. BMJ Open. 2020;10:e036400. [PMID: 32430452 DOI: 10.1136/bmjopen-2019-036400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 43 |
Silva LC, Seixas RBPM, de Carvalho E. Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors. Pediatr Gastroenterol Hepatol Nutr 2020;23:286-96. [PMID: 32483550 DOI: 10.5223/pghn.2020.23.3.286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 44 |
Arvanitis M, Hart LC, DeWalt DA, Díaz-González de Ferris ME, Sawicki GS, Long MD, Martin CF, Kappelman MD. Transition Readiness Not Associated With Measures of Health in Youth With IBD. Inflamm Bowel Dis 2021;27:49-57. [PMID: 32109284 DOI: 10.1093/ibd/izaa026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 45 |
Lopez RN, McCombie A, Gearry RB, Day AS. Impact of a Camp upon Disease-Specific Knowledge and Quality of Life in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Intest Dis 2020;5:65-9. [PMID: 32596256 DOI: 10.1159/000505918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Jafari S, Otley A, Vahed H, Heidari E, Khakshour A, Tehranian S, Mehdizadeh A, Shojaei P, Kianifar H, Day AS, Sayedi J. Validation of the Persian Version of IMPACT-III Quality of Life Questionnaire in Iranian Children with Inflammatory Bowel Disease. Iran J Pediatr 2020;30. [DOI: 10.5812/ijp.86281] [Reference Citation Analysis]
|
| 47 |
Cushman GK, Stolz MG, Shih S, Blount R, Otley A, Talmadge C, Grant A, Reed B. Parent IMPACT-III: Development and Validation of an Inflammatory Bowel Disease-specific Health-related Quality-of-life Measure. J Pediatr Gastroenterol Nutr 2020;70:205-10. [PMID: 31978018 DOI: 10.1097/MPG.0000000000002540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Bramuzzo M, De Carlo C, Arrigo S, Pavanello PM, Canaletti C, Giudici F, Agrusti A, Martelossi S, Di Leo G, Barbi E. Parental Psychological Factors and Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:211-7. [PMID: 31978019 DOI: 10.1097/MPG.0000000000002548] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 49 |
Dipasquale V, Antonelli E, Cannavò L, Cavatoi G, Romeo C, Trimarchi G, Navarra G, Romano C. Surgery-Related Quality of Life of Pediatric Patients With Crohn's Disease. Front Pediatr 2020;8:608370. [PMID: 33392119 DOI: 10.3389/fped.2020.608370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Turner D, Griffiths AM, Wilson D, Mould DR, Baldassano RN, Russell RK, Dubinsky M, Heyman MB, de Ridder L, Hyams J, Martin de Carpi J, Conklin L, Faubion WA, Koletzko S, Bousvaros A, Ruemmele FM. Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary. Gut 2020;69:32-41. [PMID: 30979718 DOI: 10.1136/gutjnl-2018-317987] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 51 |
Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, Theuns-Valks SDM, Hillegers MHJ, Escher JC, Utens EMWJ. Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial. J Pediatr Psychol 2018;43:967-80. [PMID: 29850915 DOI: 10.1093/jpepsy/jsy029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 52 |
Stapersma L, van den Brink G, van der Ende J, Bodelier AG, van Wering HM, Hurkmans PCWM, Mearin ML, van der Meulen-de Jong AE, Escher JC, Utens EMWJ. Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease. Int J Behav Med 2019;26:415-26. [PMID: 31183787 DOI: 10.1007/s12529-019-09791-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 53 |
De Carlo C, Bramuzzo M, Canaletti C, Udina C, Cozzi G, Pavanello PM, Rampado S, Martelossi S, Giudici F, Di Leo G, Barbi E. The Role of Distress and Pain Catastrophizing on the Health-related Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:e99-e104. [PMID: 31335840 DOI: 10.1097/MPG.0000000000002447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 54 |
Turner D. Particularities of IBD Trials in Children. CPD 2019;25:69-72. [DOI: 10.2174/1381612825666190307125511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 55 |
Eloi C, Foulon G, Bridoux-Henno L, Breton E, Pelatan C, Chaillou E, Grimal I, Darviot E, Carré E, Gastineau S, Tourtelier Y, Nicaise D, Rousseau C, Dabadie A. Inflammatory Bowel Diseases and School Absenteeism. J Pediatr Gastroenterol Nutr 2019;68:541-6. [PMID: 30418416 DOI: 10.1097/MPG.0000000000002207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 56 |
Cohen JS, Lyons JS, Benchimol EI, Carman N, Guertin C, Mack DR. The pediatric inflammatory bowel disease INTERMED: A new clinical tool to assess psychosocial needs. J Psychosom Res 2019;119:26-33. [PMID: 30947814 DOI: 10.1016/j.jpsychores.2019.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Caes L, Chambers CT, Otley A, Stinson J. Pain and quality of life in youth with inflammatory bowel disease: the role of parent and youth perspectives on family functioning. Pain Rep 2019;4:e715. [PMID: 31041418 DOI: 10.1097/PR9.0000000000000715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 58 |
Kim S, Park S, Kang Y, Kim JE, Kang B, Choe BH, Lee YJ, Park JH, Yang HR, Lee SH, Kim KM, Ryoo E, Tchah H, Shim JO, Koh H. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study. J Pediatr Gastroenterol Nutr 2019;68:45-9. [PMID: 30052570 DOI: 10.1097/MPG.0000000000002119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 59 |
Kim S, Park S, Kang Y, Kwon N, Koh H. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease. Acta Paediatr 2019;108:138-42. [PMID: 29998507 DOI: 10.1111/apa.14498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 60 |
Freckmann M, Seipp A, Laass MW, Koletzko S, Claßen M, Ballauff A, Peplies J, Timmer A. School-related experience and performance with inflammatory bowel disease: results from a cross-sectional survey in 675 children and their parents. BMJ Open Gastroenterol 2018;5:e000236. [PMID: 30538821 DOI: 10.1136/bmjgast-2018-000236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Lucia Casadonte CJ, Brown J, Strople J, Neighbors K, Fei L, Alonso EM. Low Insulin-like Growth Factor-1 Influences Fatigue and Quality of Life in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:616-21. [PMID: 29901552 DOI: 10.1097/MPG.0000000000002057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 62 |
Hoffenberg EJ, McWilliams SK, Mikulich-Gilbertson SK, Murphy BV, Lagueux M, Robbins K, Hoffenberg AS, de Zoeten E, Hopfer CJ. Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. J Pediatr 2018;199:99-105. [PMID: 29673723 DOI: 10.1016/j.jpeds.2018.03.041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 63 |
van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358-69. [PMID: 29897134 DOI: 10.1111/apt.14832] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 64 |
Cushing CC, Threlkeld MRS, Martinez-Leo B, Hall J, Hossain M, Dickie BH, Rymeski B, Helmrath M, Zeller MH, Frischer JS. Initial development and validation of a fecal incontinence-specific quality of life measure. J Pediatr Surg 2018;53:1148-53. [PMID: 29685491 DOI: 10.1016/j.jpedsurg.2018.02.076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 65 |
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis 2018;24:966-76. [PMID: 29688466 DOI: 10.1093/ibd/izy015] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 66 |
Diederen K, Haverman L, Grootenhuis MA, Benninga MA, Kindermann A. Parental Distress and Quality of Life in Pediatric Inflammatory Bowel Disease: Implications for the Outpatient Clinic. J Pediatr Gastroenterol Nutr 2018;66:630-6. [PMID: 28953528 DOI: 10.1097/MPG.0000000000001756] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 67 |
Heida A, Dijkstra A, Muller Kobold A, Rossen JW, Kindermann A, Kokke F, de Meij T, Norbruis O, Weersma RK, Wessels M, Hummel T, Escher J, van Wering H, Hendriks D, Mearin L, Groen H, Verkade HJ, van Rheenen PF. Efficacy of Home Telemonitoring versus Conventional Follow-up: A Randomized Controlled Trial among Teenagers with Inflammatory Bowel Disease. J Crohns Colitis 2018;12:432-41. [PMID: 29228230 DOI: 10.1093/ecco-jcc/jjx169] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 68 |
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response. J Pediatr Gastroenterol Nutr 2018;66:274-80. [PMID: 29356768 DOI: 10.1097/MPG.0000000000001679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 69 |
Uggla C, Lindh V, Lind T, Lindkvist M. IMPACT-III is a valid and reliable questionnaire for assessing health-related quality of life in Swedish children with inflammatory bowel disease. Acta Paediatr 2018;107:347-53. [PMID: 29032599 DOI: 10.1111/apa.14119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Plevinsky JM, Wojtowicz AA, Poulopoulos N, Schneider KL, Greenley RN. Perceived Impairment in Sports Participation in Adolescents With Inflammatory Bowel Diseases: A Preliminary Examination. J Pediatr Gastroenterol Nutr 2018;66:79-83. [PMID: 28505049 DOI: 10.1097/MPG.0000000000001633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 71 |
Izaguirre MR, Taft T, Keefer L. Validation of a Self-efficacy Scale for Adolescents and Young Adults With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:546-50. [PMID: 28248793 DOI: 10.1097/MPG.0000000000001552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 72 |
Carlsen K, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:539-45. [PMID: 28169974 DOI: 10.1097/MPG.0000000000001540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 73 |
Reigada LC, Moore MT, Martin CF, Kappelman MD. Psychometric Evaluation of the IBD-Specific Anxiety Scale: A Novel Measure of Disease-Related Anxiety for Adolescents With IBD. Journal of Pediatric Psychology 2018;43:413-22. [DOI: 10.1093/jpepsy/jsx121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 74 |
Flood E, Silberg DG, Romero B, Beusterien K, Erder MH, Cuffari C. Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings. BMC Res Notes 2017;10:491. [PMID: 28946891 DOI: 10.1186/s13104-017-2814-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 75 |
Chen XL, Zhong LH, Wen Y, Liu TW, Li XY, Hou ZK, Hu Y, Mo CW, Liu FB. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes 2017;15:177. [PMID: 28915891 DOI: 10.1186/s12955-017-0753-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 76 |
Carlsen K, Houen G, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1473-82. [PMID: 28617758 DOI: 10.1097/MIB.0000000000001170] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 77 |
McCombie A, Gearry RB, Lopez RN, Lönnfors S, Day AS. Enhancements in Confidence, Acceptance, and Friendship at a Summer Camp for Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:311-3. [PMID: 28118290 DOI: 10.1097/MPG.0000000000001526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 78 |
Grant A, Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. In: Mamula P, Grossman AB, Baldassano RN, Kelsen JR, Markowitz JE, editors. Pediatric Inflammatory Bowel Disease. Cham: Springer International Publishing; 2017. pp. 625-38. [DOI: 10.1007/978-3-319-49215-5_51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 79 |
Cohen SA, Aloi M, Arumugam R, Baker R, Bax K, Kierkuś J, Koletzko S, Lionetti P, Persson T, Eklund S. Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children. Curr Med Res Opin 2017;33:1261-8. [PMID: 28420280 DOI: 10.1080/03007995.2017.1313213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 80 |
Carlsen K, Jakobsen C, Houen G, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial. Inflamm Bowel Dis 2017;23:357-65. [PMID: 28221247 DOI: 10.1097/MIB.0000000000001026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 81 |
Faubion WA, Dubinsky M, Ruemmele FM, Escher J, Rosh J, Hyams JS, Eichner S, Li Y, Reilly N, Thakkar RB, Robinson AM, Lazar A. Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease. Inflamm Bowel Dis 2017;23:453-60. [PMID: 28129288 DOI: 10.1097/MIB.0000000000001021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 82 |
Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; The Swiss IBD Cohort Study Group. Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease. Qual Life Res 2017;26:1617-26. [DOI: 10.1007/s11136-017-1513-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 83 |
Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 84 |
Corica D, Romano C. Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review. J Clin Gastroenterol 2017;51:100-10. [PMID: 27636407 DOI: 10.1097/MCG.0000000000000696] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 85 |
Otley AR, Day AS, Zachos M. Nutritional Management of Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_27] [Reference Citation Analysis]
|
| 86 |
Sahn B, Markowitz J. The Natural History of Crohn Disease in Children. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_7] [Reference Citation Analysis]
|
| 87 |
Carlsen K, Munkholm P, Burisch J. Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life? Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_25] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 88 |
Cozijnsen MA, van Pieterson M, Samsom JN, Escher JC, de Ridder L. Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial. BMJ Open Gastroenterol 2016;3:e000123. [PMID: 28090335 DOI: 10.1136/bmjgast-2016-000123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 89 |
Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, Neigut DA, Saps M, Franciosi JP, Denham JM, Zacur GM, Dark CV, Bendo CB, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. Gastrointestinal Symptoms Predictors of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:e186-92. [PMID: 27749610 DOI: 10.1097/MPG.0000000000001428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 90 |
Gupta N, Zidan M, Moltz K, Adhikari A, Buggs-Saxton C, Zidan H, Abushanab D, Lteif A, Edwin C. Development and Validation of a Pediatric Endocrine Knowledge Assessment Questionnaire: Impact of ac Pediatric Endocrine Knowledge Assessment Questionnaire Intervention Study. J Clin Res Pediatr Endocrinol 2016;8:411-8. [PMID: 27353948 DOI: 10.4274/jcrpe.3171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 91 |
Cunningham C, Cho E, Shaffer ML, Bradford MC, Palermo T. Screening for Psychosocial and Family Risk in Pediatric Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2016;63:e158-62. [PMID: 27875504 DOI: 10.1097/MPG.0000000000001426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 92 |
Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, Murphy TB, Claar RL, Feld SI, Christie DL, Abdullah B, DuPen MM, Swanson KS, Baker MD, Stoner SA, Whitehead WE. Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:2134-48. [PMID: 27542131 DOI: 10.1097/MIB.0000000000000881] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 93 |
Knod JL, Holder M, Cortez AR, Martinez-Leo B, Kern P, Saeed S, Warner B, Dickie B, Falcone RA, von Allmen D, Frischer JS. Surgical outcomes, bowel habits and quality of life in young patients after ileoanal anastomosis for ulcerative colitis. J Pediatr Surg 2016;51:1246-50. [PMID: 27417342 DOI: 10.1016/j.jpedsurg.2016.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 94 |
Arvanitis M, DeWalt DA, Martin CF, Long MD, Chen W, Jaeger B, Sandler RS, Kappelman MD. Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease. J Pediatr 2016;174:153-159.e2. [PMID: 27157449 DOI: 10.1016/j.jpeds.2016.03.069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 95 |
Kochar B, Aldridge M, Cook SF, Bright R, Mallette M, Moniz H, Shah SA, LeLeiko NS, Shapiro J, Sands BE, Chen W, Jaeger E, Galanko J, Long MD, Martin CF, Sandler RS, Kappelman MD. Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease. J Med Internet Res 2016;18:e124. [PMID: 27261008 DOI: 10.2196/jmir.5655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 96 |
Reed-Knight B, Lee JL, Greenley RN, Lewis JD, Blount RL. Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:963-7. [PMID: 26818418 DOI: 10.1097/MIB.0000000000000686] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 97 |
Higuchi LM, Regan BP, Bousvaros A. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_30] [Reference Citation Analysis]
|
| 98 |
Tung J, Grunow JE, Jacobs N. Pilot Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz Game. J Pediatr Gastroenterol Nutr 2015;61:292-6. [PMID: 25793902 DOI: 10.1097/MPG.0000000000000788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 99 |
Marshman Z, Gupta E, Baker SR, Robinson PG, Owens J, Rodd HD, Benson PE, Gibson B. Seen and heard: towards child participation in dental research. Int J Paediatr Dent 2015;25:375-82. [PMID: 26061706 DOI: 10.1111/ipd.12179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 100 |
Akobeng AK, O'Leary N, Vail A, Brown N, Widiatmoko D, Fagbemi A, Thomas AG. Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation. EBioMedicine 2015;2:1251-6. [PMID: 26501125 DOI: 10.1016/j.ebiom.2015.08.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 101 |
Lee D, Baldassano RN, Otley AR, Albenberg L, Griffiths AM, Compher C, Chen EZ, Li H, Gilroy E, Nessel L, Grant A, Chehoud C, Bushman FD, Wu GD, Lewis JD. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease. Inflamm Bowel Dis 2015;21:1786-93. [PMID: 25970545 DOI: 10.1097/MIB.0000000000000426] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 102 |
Szabó D, Hosszú É, Arató A, Müller KE, Béres N, Lakatos PL, Papp M, Dezsőfi A, Szabó AJ, Szűcs D, Veres G. Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease. Dig Liver Dis 2015;47:652-7. [PMID: 26074152 DOI: 10.1016/j.dld.2015.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 103 |
Clifford Lind M, Tornberg ÅB. Psychometric properties of the Swedish version of the Functional Disability Inventory. European Journal of Physiotherapy 2015;17:116-122. [DOI: 10.3109/21679169.2015.1046486] [Reference Citation Analysis]
|
| 104 |
Heida A, Dijkstra A, Groen H, Muller Kobold A, Verkade H, van Rheenen P. Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials 2015;16:271. [PMID: 26073770 DOI: 10.1186/s13063-015-0787-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 105 |
Gray WN, Boyle SL, Graef DM, Janicke DM, Jolley CD, Denson LA, Baldassano RN, Hommel KA. Health-related quality of life in youth with Crohn disease: role of disease activity and parenting stress. J Pediatr Gastroenterol Nutr 2015;60:749-53. [PMID: 25564807 DOI: 10.1097/MPG.0000000000000696] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 106 |
Hommel KA, Gray WN, Hente E, Loreaux K, Ittenbach RF, Maddux M, Baldassano R, Sylvester F, Crandall W, Doarn C, Heyman MB, Keljo D, Denson LA. The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology. Contemp Clin Trials 2015;43:105-13. [PMID: 26003436 DOI: 10.1016/j.cct.2015.05.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 107 |
Bollegala N, Nguyen GC. Transitioning the Adolescent with IBD from Pediatric to Adult Care: A Review of the Literature. Gastroenterol Res Pract. 2015;2015:853530. [PMID: 26064100 DOI: 10.1155/2015/853530] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 108 |
Varni JW, Franciosi JP, Shulman RJ, Saeed S, Nurko S, Neigut DA, Bendo CB, Patel AS, Self MM, Saps M, Zacur GM, Denham J, Dark CV, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls. Inflamm Bowel Dis 2015;21:1115-24. [PMID: 25793327 DOI: 10.1097/MIB.0000000000000351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 109 |
Abdovic S, Pavic AM, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis 2015;21:818-23. [PMID: 25742398 DOI: 10.1097/MIB.0000000000000324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 110 |
Engelmann G, Erhard D, Petersen M, Parzer P, Schlarb AA, Resch F, Brunner R, Hoffmann GF, Lenhartz H, Richterich A. Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity. Child Psychiatry Hum Dev 2015;46:300-7. [PMID: 24838299 DOI: 10.1007/s10578-014-0471-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 111 |
Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut 2015;64:438-46. [PMID: 24821616 DOI: 10.1136/gutjnl-2014-307008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 112 |
Kelly MS, Hannan M, Cassidy B, Hidas G, Selby B, Khoury AE, McLorie G. Development, reliability and validation of a neurogenic bowel dysfunction score in pediatric patients with spina bifida. Neurourol Urodyn 2016;35:212-7. [PMID: 25400229 DOI: 10.1002/nau.22694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 113 |
Loreaux KL, Gray WN, Denson LA, Hommel KA. Health-Related Quality of Life in Adolescents With Inflammatory Bowel Disease: The Relation of Parent and Adolescent Depressive Symptoms. Children's Health Care 2014;44:119-35. [DOI: 10.1080/02739615.2014.912943] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Ng V, Nicholas D, Dhawan A, Yazigi N, Ee L, Stormon M, Gilmour S, Schreiber R, Taylor R, Otley A; PeLTQL study group. Development and validation of the pediatric liver transplantation quality of life: a disease-specific quality of life measure for pediatric liver transplant recipients. J Pediatr 2014;165:547-55.e7. [PMID: 24976329 DOI: 10.1016/j.jpeds.2014.05.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 115 |
Plevinsky JM, Greenley RN. Exploring health-related quality of life and social functioning in adolescents with inflammatory bowel diseases after attending camp oasis and participating in a Facebook group. Inflamm Bowel Dis 2014;20:1611-7. [PMID: 25025714 DOI: 10.1097/MIB.0000000000000120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 116 |
Szabó D, Kökönyei G, Arató A, Dezsőfi A, Molnár K, Müller KE, Lakatos PL, Papp M, Lovász BD, Golovics PA, Cseh A, Veres G. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease. J Crohns Colitis 2014;8:747-55. [PMID: 24434181 DOI: 10.1016/j.crohns.2013.12.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 117 |
Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 2014;12:1246-56.e6. [PMID: 24534550 DOI: 10.1016/j.cgh.2014.02.016] [Cited by in Crossref: 183] [Cited by in F6Publishing: 182] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 118 |
Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, Ducharme P, Gonzalez-Heydrich J, Keljo D, Srinath A, Bousvaros A, Kirshner M, Newara M, Kupfer D, DeMaso DR. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 2014;53:726-35. [PMID: 24954822 DOI: 10.1016/j.jaac.2014.04.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 119 |
Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; Swiss IBD Cohort Study Group. Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. J Crohns Colitis 2014;8:641-8. [PMID: 24342766 DOI: 10.1016/j.crohns.2013.11.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 120 |
Szigethy EM, Youk AO, Benhayon D, Fairclough DL, Newara MC, Kirshner MA, Bujoreanu SI, Mrakotsky C, Bousvaros A, Srinath AI, Keljo DJ, Kupfer DJ, DeMaso DR. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:574-81. [PMID: 24345836 DOI: 10.1097/MPG.0000000000000262] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 121 |
Gilchrist F, Rodd H, Deery C, Marshman Z. Assessment of the quality of measures of child oral health-related quality of life. BMC Oral Health 2014;14:40. [PMID: 24758535 DOI: 10.1186/1472-6831-14-40] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 122 |
Gallo J, Grant A, Otley AR, Orsi M, MacIntyre B, Gauvry S, Lifschitz C. Do parents and children agree? Quality-of-life assessment of children with inflammatory bowel disease and their parents. J Pediatr Gastroenterol Nutr 2014;58:481-5. [PMID: 24663034 DOI: 10.1097/MPG.0000000000000236] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 123 |
Bishop J, Lemberg DA, Day A. Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther. 2014;5:1-13. [PMID: 24729736 DOI: 10.2147/ahmt.s37956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 124 |
Abdovic S, Mocic Pavic A, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease. J Crohns Colitis 2013;7:908-15. [PMID: 23333037 DOI: 10.1016/j.crohns.2012.12.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 125 |
Day AS. A review of the use of complementary and alternative medicines by children with inflammatory bowel disease. Front Pediatr 2013;1:9. [PMID: 24400255 DOI: 10.3389/fped.2013.00009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 126 |
Smith JP, Field D, Bingaman SI, Evans R, Mauger DT. Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study. J Clin Gastroenterol 2013;47:339-45. [PMID: 23188075 DOI: 10.1097/MCG.0b013e3182702f2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 127 |
Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013;56:449-58. [PMID: 23287808 DOI: 10.1097/MPG.0b013e3182841263] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 128 |
Malik BA, Gibbons K, Spady D, Lees G, Otley A, Huynh HQ. Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy. Int J Colorectal Dis 2013;28:325-33. [PMID: 22914964 DOI: 10.1007/s00384-012-1561-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 129 |
Otley A, Day AS, Zachos M. Nutritional Management of Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_28] [Reference Citation Analysis]
|
| 130 |
Cucchiara S, Di Nardo G, Aloi M. Clinical Trials (Clinician Perspective). Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_42] [Reference Citation Analysis]
|
| 131 |
Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_45] [Reference Citation Analysis]
|
| 132 |
Markowitz JF. The Natural History of Crohn Disease in Children. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_7] [Reference Citation Analysis]
|
| 133 |
Uchida K, Araki T, Kusunoki M. History of and current issues affecting surgery for pediatric ulcerative colitis. Surg Today 2013;43:1219-31. [PMID: 23203770 DOI: 10.1007/s00595-012-0434-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 134 |
Rosen D, Kathy-Hoffstadter-Thal, Bao R, Tomaino J, Ceballos C, Russell GJ, Benkov KJ. Analysis of current treatments used in clinical practice in a pediatric summer camp population for children with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:1818-24. [PMID: 22069120 DOI: 10.1002/ibd.22837] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 135 |
Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis 2012;6:665-73. [PMID: 22398103 DOI: 10.1016/j.crohns.2011.11.017] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 136 |
DeBoer MD, Barnes BH, Stygles NA, Sutphen JL, Borowitz SM. Changes in inflammation and QoL after a single dose of infliximab during ongoing IBD treatment. J Pediatr Gastroenterol Nutr 2012;54:486-90. [PMID: 21946833 DOI: 10.1097/MPG.0b013e3182382ee3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 137 |
Lowe W, Kenwright D, Wyeth J, Blair N. Crohn disease: effect on children's lifestyles. J Pediatr Gastroenterol Nutr 2012;54:397-400. [PMID: 21857249 DOI: 10.1097/MPG.0b013e318231cf17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 138 |
Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012;24:64-9. [PMID: 21989119 DOI: 10.1097/MEG.0b013e32834d09f1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 139 |
Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:480-8. [PMID: 21822149 DOI: 10.1097/MPG.0b013e31822f2c32] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 140 |
Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG. Validation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:280-6. [PMID: 21865975 DOI: 10.1097/MPG.0b013e3182165d10] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 141 |
Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in Ireland. J Pediatr Gastroenterol Nutr 2011;53:275-9. [PMID: 21865974 DOI: 10.1097/MPG.0b013e318214c131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 142 |
Reigada LC, Bruzzese JM, Benkov KJ, Levy J, Waxman AR, Petkova E, Warner CM. Illness-specific anxiety: implications for functioning and utilization of medical services in adolescents with inflammatory bowel disease. J Spec Pediatr Nurs 2011;16:207-15. [PMID: 21702881 DOI: 10.1111/j.1744-6155.2011.00292.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 143 |
Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1581-6. [PMID: 21674715 DOI: 10.1002/ibd.21520] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 144 |
Lee JJ, Colman RJ, Mitchell PD, Atmadja ML, Bousvaros A, Lightdale JR. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr 2011;52:708-13. [PMID: 21593644 DOI: 10.1097/MPG.0b013e3182099018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 145 |
Herzer M, Denson LA, Baldassano RN, Hommel KA. Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:295-9. [PMID: 21297508 DOI: 10.1097/MPG.0b013e3181f5714e] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 146 |
Herzer M, Denson LA, Baldassano RN, Hommel KA. Family functioning and health-related quality of life in adolescents with pediatric inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:95-100. [PMID: 21079514 DOI: 10.1097/MEG.0b013e3283417abb] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 147 |
Dubinsky M. State-of-the-Art Management of the Pediatric IBD Patient. Inflammatory Bowel Disease 2011. [DOI: 10.1007/978-1-60327-433-3_10] [Reference Citation Analysis]
|
| 148 |
Huamán JW, Casellas F, Borruel N, Peláez A, Torrejón A, Castells I, Masachs M, Varela E, Guarner F. Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of life. J Crohns Colitis 2010;4:637-41. [PMID: 21122573 DOI: 10.1016/j.crohns.2010.07.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 149 |
Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ. A randomized controlled trial of growth hormone in active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2010;51:130-9. [PMID: 20453679 DOI: 10.1097/MPG.0b013e3181c992d6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 150 |
Kelsen JR, Rosh J, Heyman M, Winter HS, Ferry G, Cohen S, Mamula P, Baldassano RN. Phase I trial of sargramostim in pediatric Crohn's disease. Inflamm Bowel Dis 2010;16:1203-8. [PMID: 20052780 DOI: 10.1002/ibd.21204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 151 |
Hill R, Lewindon P, Muir R, Grangé I, Connor F, Ee L, Withers G, Cleghorn G, Davies P. Quality of life in children with Crohn disease. J Pediatr Gastroenterol Nutr 2010;51:35-40. [PMID: 20410845 DOI: 10.1097/MPG.0b013e3181c2c0ef] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 152 |
Uchida K, Araki T, Inoue M, Otake K, Yoshiyama S, Koike Y, Matsushita K, Okita Y, Miki C, Kusunoki M. Poor catch-up growth after proctocolectomy in pediatric patients with ulcerative colitis receiving prolonged steroid therapy. Pediatr Surg Int 2010;26:373-7. [PMID: 20182750 DOI: 10.1007/s00383-010-2577-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 153 |
Turner D, Griffiths AM, Mack D, Otley AR, Seow CH, Steinhart AH, Silverberg MS, Hyams J, Guyatt GH. Assessing disease activity in ulcerative colitis: patients or their physicians? Inflamm Bowel Dis 2010;16:651-6. [PMID: 19708058 DOI: 10.1002/ibd.21088] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 154 |
Greenley RN, Hommel KA, Nebel J, Raboin T, Li SH, Simpson P, Mackner L. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857-869. [PMID: 20123705 DOI: 10.1093/jpepsy/jsp120] [Cited by in Crossref: 174] [Cited by in F6Publishing: 182] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 155 |
Wexner SD, Frattini JC. Quality of Life in Crohn’s Disease. Handbook of Disease Burdens and Quality of Life Measures 2010. [DOI: 10.1007/978-0-387-78665-0_127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 156 |
Rajmil L, Perestelo-Pérez L, Herdman M. Quality of life and rare diseases. Adv Exp Med Biol 2010;686:251-72. [PMID: 20824450 DOI: 10.1007/978-90-481-9485-8_15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 157 |
Veres G, Putz R, Szabó D, Molnár K, Bodánszky H, Dezsofi A, Arató A. [Adalimumab treatment in infliximab-resistant pediatric patient with Crohn’s disease]. Orv Hetil. 2009;150:1858-1860. [PMID: 19789146 DOI: 10.1556/oh.2009.28731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 158 |
de Carpi JM. Aspectos psicosociales de la enfermedad inflamatoria intestinal pediátrica: aceptación y adaptación a la enfermedad. Gastroenterología y Hepatología 2009;32:25-30. [DOI: 10.1016/s0210-5705(09)72602-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 159 |
Szigethy E, Hardy D, Craig AE, Low C, Kukic S. Girls connect: effects of a support group for teenage girls with inflammatory bowel disease and their mothers. Inflamm Bowel Dis 2009;15:1127-8. [PMID: 18972566 DOI: 10.1002/ibd.20775] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 160 |
Marcus SB, Strople JA, Neighbors K, Weissberg-Benchell J, Nelson SP, Limbers C, Varni JW, Alonso EM. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:554-61. [PMID: 19418604 DOI: 10.1016/j.cgh.2009.01.022] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 161 |
Otley A. Evaluating health utilities in adolescents: raising the profile of an alternative method for assessing health-related quality of life. J Pediatr 2009;154:476-8. [PMID: 19324215 DOI: 10.1016/j.jpeds.2008.11.039] [Reference Citation Analysis]
|
| 162 |
Cunningham C, Greenley RN. Inflammatory Bowel Disease. Behavioral Approaches to Chronic Disease in Adolescence 2009. [DOI: 10.1007/978-0-387-87687-0_20] [Reference Citation Analysis]
|
| 163 |
Nanigian DK, Nguyen T, Tanaka ST, Cambio A, Digrande A, Kurzrock EA. Development and Validation of the Fecal Incontinence and Constipation Quality of Life Measure in Children With Spina Bifida. Journal of Urology 2008;180:1770-3. [DOI: 10.1016/j.juro.2008.03.103] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 164 |
Solans M, Pane S, Estrada M, Serra-sutton V, Berra S, Herdman M, Alonso J, Rajmil L. Health-Related Quality of Life Measurement in Children and Adolescents: A Systematic Review of Generic and Disease-Specific Instruments. Value in Health 2008;11:742-64. [DOI: 10.1111/j.1524-4733.2007.00293.x] [Cited by in Crossref: 360] [Cited by in F6Publishing: 377] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 165 |
Heuschkel R, Salvestrini C, Beattie RM, Hildebrand H, Walters T, Griffiths A. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008;14:839-49. [PMID: 18266237 DOI: 10.1002/ibd.20378] [Cited by in Crossref: 145] [Cited by in F6Publishing: 128] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 166 |
Elkjaer M, Moser G, Reinisch W, Durovicova D, Lukas M, Vucelic B, Wewer V, Frederic Colombel J, Shuhaibar M, O'Morain C, Politi P, Odes S, Bernklev T, Oresland T, Nikulina I, Belousova E, Van der Eijk I, Munkholm P. IBD patients need in health quality of care ECCO consensus. J Crohns Colitis 2008;2:181-8. [PMID: 21172209 DOI: 10.1016/j.crohns.2008.02.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 167 |
Perrin JM, Kuhlthau K, Chughtai A, Romm D, Kirschner BS, Ferry GD, Cohen SA, Gold BD, Heyman MB, Baldassano RN, Winter HS. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr 2008;46:164-71. [PMID: 18223375 DOI: 10.1097/MPG.0b013e31812f7f4e] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 168 |
Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 413-420 [PMID: 18200664 DOI: 10.3748/wjg.14.413] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 169 |
Ogden CA, Abbott J, Aggett P, Derkx BH, Maity S, Thomas AG. Pilot evaluation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2008;46:117-20. [PMID: 18162847 DOI: 10.1097/01.mpg.0000304467.45541.bb] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 170 |
Markowitz J. The Natural History of Pediatric Crohn Disease. Pediatric Inflammatory Bowel Disease. [DOI: 10.1007/978-0-387-73481-1_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 171 |
Cucchiara S, Borrelli O. Clinical Trials (Clinical Perspective). Pediatric Inflammatory Bowel Disease. [DOI: 10.1007/978-0-387-73481-1_40] [Reference Citation Analysis]
|
| 172 |
Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease. [DOI: 10.1007/978-0-387-73481-1_43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 173 |
Nicholas DB, Otley A, Smith C, Avolio J, Munk M, Griffiths AM. Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination. Health Qual Life Outcomes. 2007;5:28. [PMID: 17531097 DOI: 10.1186/1477-7525-5-28] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 174 |
Maity S, Thomas AG. Quality of life in paediatric gastrointestinal and liver disease: a systematic review. J Pediatr Gastroenterol Nutr 2007;44:540-54. [PMID: 17460485 DOI: 10.1097/MPG.0b013e3180332df0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 175 |
Eiser C, Jenney M. Measuring quality of life. Arch Dis Child 2007;92:348-50. [PMID: 17376942 DOI: 10.1136/adc.2005.086405] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 176 |
Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R; REACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007;132:863-73; quiz 1165-6. [PMID: 17324398 DOI: 10.1053/j.gastro.2006.12.003] [Cited by in Crossref: 591] [Cited by in F6Publishing: 615] [Article Influence: 36.9] [Reference Citation Analysis]
|
| 177 |
Kirschner BS, Huo D. Timing infliximab therapy in pediatric Crohn's disease. Gastroenterology 2007;132:1167-70. [PMID: 17383435 DOI: 10.1053/j.gastro.2007.01.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 178 |
Hyams JS, Wilson DC, Thomas A, Heuschkel R, Mitton S, Mitchell B, Daniels R, Libonati MA, Zanker S, Kugathasan S; International Natalizumab CD305 Trial Group. Natalizumab therapy for moderate to severe Crohn disease in adolescents. J Pediatr Gastroenterol Nutr 2007;44:185-91. [PMID: 17255829 DOI: 10.1097/01.mpg.0000252191.05170.e7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 179 |
Persad R, Jaffer I, Issenman RM. The prevalence of long bone fractures in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006;43:597-602. [PMID: 17130734 DOI: 10.1097/01.mpg.0000237926.22976.55] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 180 |
Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Evans J, Blanchard W, Hyams J; Pediatric IBD Collaborative Research Group. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:684-91. [PMID: 16917222 DOI: 10.1097/00054725-200608000-00003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 181 |
Blank C, Switzer GE. The use of questionnaires in pediatric inflammatory bowel disease. Curr Gastroenterol Rep 2006;8:244-7. [DOI: 10.1007/s11894-006-0082-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 182 |
Noeker M. Psychologische Diagnostik bei chronischer Erkrankung. Monatsschr Kinderheilkd 2006;154:326-337. [DOI: 10.1007/s00112-006-1310-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 183 |
Davis E, Waters E, Mackinnon A, Reddihough D, Graham HK, Mehmet-Radji O, Boyd R. Paediatric quality of life instruments: a review of the impact of the conceptual framework on outcomes. Dev Med Child Neurol 2006;48:311-8. [PMID: 16542522 DOI: 10.1017/S0012162206000673] [Cited by in Crossref: 178] [Cited by in F6Publishing: 181] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 184 |
Calderón JL, Morales LS, Liu H, Hays RD. Variation in the readability of items within surveys. Am J Med Qual 2006;21:49-56. [PMID: 16401705 DOI: 10.1177/1062860605283572] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 185 |
Sands BE, Abreu MT, Ferry GD, Griffiths AM, Hanauer SB, Isaacs KL, Lewis JD, Sandborn WJ, Steinhart AH. Design issues and outcomes in IBD clinical trials. Inflamm Bowel Dis 2005;11 Suppl 1:S22-8. [PMID: 16254479 DOI: 10.1097/01.mib.0000184849.38816.39] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 186 |
Casellas F, Arenas JI, Baudet JS, Fábregas S, García N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005;11:488-96. [PMID: 15867589 DOI: 10.1097/01.mib.0000159661.55028.56] [Cited by in Crossref: 194] [Cited by in F6Publishing: 158] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 187 |
Day A, Whitten K, Bohane T. Childhood inflammatory bowel disease: Parental concerns and expectations. World J Gastroenterol 2005; 11(7): 1028-1031 [PMID: 15742408 DOI: 10.3748/wjg.v11.i7.1028] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 188 |
Griffiths AM, Otley AR, Hyams J, Quiros AR, Grand RJ, Bousvaros A, Feagan BG, Ferry GR. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis 2005;11:185-96. [PMID: 15677913 DOI: 10.1097/00054725-200502000-00013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 189 |
Derkx HHF, van der Zaag-loonen HJ, Grootenhuis MA, Last BF. Adolescenten met ibd: wat is de rol van coping en is er een relatie met hun kwaliteit van leven? KIND 2005;73:267-272. [DOI: 10.1007/bf03061591] [Reference Citation Analysis]
|
| 190 |
Shepanski MA, Hurd LB, Culton K, Markowitz JE, Mamula P, Baldassano RN. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005;11:164-70. [PMID: 15677910 DOI: 10.1097/00054725-200502000-00010] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 191 |
De Civita M, Regier D, Alamgir AH, Anis AH, Fitzgerald MJ, Marra CA. Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications. PharmacoEconomics 2005;23:659-85. [DOI: 10.2165/00019053-200523070-00003] [Cited by in Crossref: 182] [Cited by in F6Publishing: 185] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 192 |
Avitzur Y, De Luca E, Cantos M, Jimenez-rivera C, Jones N, Fecteau A, Grant D, Lee Ng V. Health Status Ten Years After Pediatric Liver Transplantation—Looking Beyond The Graft. Transplantation 2004;78:566-73. [DOI: 10.1097/01.tp.0000131663.87106.1a] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 193 |
Shepanski MA, Markowitz JE, Mamula P, Hurd LB, Baldassano RN. Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original? J Pediatr Gastroenterol Nutr 2004;39:68-72. [PMID: 15187784 DOI: 10.1097/00005176-200407000-00014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 194 |
Murch SH, Baldassano R, Buller H, Chin S, Griffiths AM, Hildebrand H, Jasinsky C, Kong T, Moore D, Orsi M; Commonwealth Association of Paediatric Gastroenterology and Nutrition. Inflammatory bowel disease: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39 Suppl 2:S647-54. [PMID: 15184765 DOI: 10.1097/00005176-200406002-00011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 195 |
Bremner AR, Griffiths DM, Beattie RM. Current therapy of ulcerative colitis in children. Expert Opin Pharmacother 2004;5:37-53. [PMID: 14680434 DOI: 10.1517/14656566.5.1.37] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 196 |
van der Zaag-loonen HJ, Derkx HHF, Grootenhuis MA, Last BF. Hoe meet je de kwaliteit van leven van kinderen met een chronische ziekte. KIND 2003;71:183-7. [DOI: 10.1007/bf03061454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
